| Year |
Citation |
Score |
| 2018 |
Nam HY, Chandrashekar DS, Kundu A, Shelar S, Kho EY, Sonpavde G, Naik G, Ghatalia P, Livi CB, Varambally S, Sudarshan S. Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis. Molecular Cancer Research : McR. PMID 30131446 DOI: 10.1158/1541-7786.Mcr-17-0636 |
0.352 |
|
| 2018 |
Kundu A, Kho E, Shelar SB, Nam H, Brinkley G, Darshan S, Tang Y, Kirkman R, Crossman DK, Varambally S, Rowe GC, Wei S, Buckhaults P, Sudarshan S. Abstract 4483: Functional implications of PRDM16 loss in kidney cancer Cancer Research. 78: 4483-4483. DOI: 10.1158/1538-7445.Am2018-4483 |
0.359 |
|
| 2014 |
Shim EH, Livi CB, Rakheja D, Tan J, Benson D, Parekh V, Kho EY, Ghosh AP, Kirkman R, Velu S, Dutta S, Chenna B, Rea SL, Mishur RJ, Li Q, et al. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discovery. 4: 1290-8. PMID 25182153 DOI: 10.1158/2159-8290.Cd-13-0696 |
0.306 |
|
| 2014 |
Shim E, Livi CB, Knight J, Holmes RP, Rakheja D, Velu S, Kho E, Chenna B, Rea SL, Benson D, Kirkman R, Ghosh A, Li Q, Bae S, Wei S, et al. Abstract LB-131: Elevated (L) -2-hydroxyglutarate promotes loss of 5-hydroxymethylcytosine in clear cell renal cancer Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-131 |
0.365 |
|
| 2014 |
Ghosh A, Kirkman R, Kho E, Shim E, Sudarshan S. MP35-11 POINT MUTATIONS IN MTOR LEAD TO CONSTITUTIVE ACTIVATION OF MTOR IN RENAL CELL CARCINOMA Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1054 |
0.322 |
|
| 2013 |
Kho EY, Wang HK, Banerjee NS, Broker TR, Chow LT. HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures Proceedings of the National Academy of Sciences of the United States of America. 110: 7542-7549. PMID 23572574 DOI: 10.1073/Pnas.1304855110 |
0.316 |
|
| Show low-probability matches. |